nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—Lidocaine—EGFR—colon cancer	0.00827	0.767	CrCbGaD
Levobupivacaine—Muscular weakness—Fluorouracil—colon cancer	0.00287	0.0029	CcSEcCtD
Levobupivacaine—Sweating increased—Irinotecan—colon cancer	0.00286	0.00289	CcSEcCtD
Levobupivacaine—Dysphagia—Fluorouracil—colon cancer	0.00281	0.00284	CcSEcCtD
Levobupivacaine—Apnoea—Methotrexate—colon cancer	0.00275	0.00278	CcSEcCtD
Levobupivacaine—Extravasation—Methotrexate—colon cancer	0.00267	0.0027	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Vincristine—colon cancer	0.00263	0.00266	CcSEcCtD
Levobupivacaine—Musculoskeletal stiffness—Methotrexate—colon cancer	0.0026	0.00263	CcSEcCtD
Levobupivacaine—Skin discolouration—Methotrexate—colon cancer	0.00258	0.00261	CcSEcCtD
Levobupivacaine—Bone disorder—Methotrexate—colon cancer	0.00258	0.00261	CcSEcCtD
Levobupivacaine—Sweating—Vincristine—colon cancer	0.00258	0.00261	CcSEcCtD
Levobupivacaine—Vascular purpura—Capecitabine—colon cancer	0.00254	0.00257	CcSEcCtD
Levobupivacaine—Lidocaine—ABCB1—colon cancer	0.00252	0.233	CrCbGaD
Levobupivacaine—Sweating—Irinotecan—colon cancer	0.00251	0.00254	CcSEcCtD
Levobupivacaine—Infestation NOS—Fluorouracil—colon cancer	0.00251	0.00253	CcSEcCtD
Levobupivacaine—Infestation—Fluorouracil—colon cancer	0.00251	0.00253	CcSEcCtD
Levobupivacaine—Dysarthria—Methotrexate—colon cancer	0.00247	0.00249	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00246	0.00248	CcSEcCtD
Levobupivacaine—Urinary tract infection—Fluorouracil—colon cancer	0.00244	0.00246	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Vincristine—colon cancer	0.0024	0.00243	CcSEcCtD
Levobupivacaine—Bradycardia—Irinotecan—colon cancer	0.00239	0.00242	CcSEcCtD
Levobupivacaine—Respiratory failure—Methotrexate—colon cancer	0.00237	0.0024	CcSEcCtD
Levobupivacaine—Purpura—Capecitabine—colon cancer	0.00236	0.00238	CcSEcCtD
Levobupivacaine—Lethargy—Capecitabine—colon cancer	0.00232	0.00235	CcSEcCtD
Levobupivacaine—Osteoarthritis—Capecitabine—colon cancer	0.00227	0.0023	CcSEcCtD
Levobupivacaine—Diplopia—Capecitabine—colon cancer	0.00227	0.0023	CcSEcCtD
Levobupivacaine—Depressed level of consciousness—Methotrexate—colon cancer	0.00225	0.00228	CcSEcCtD
Levobupivacaine—Cardiac disorder—Vincristine—colon cancer	0.00224	0.00226	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Fluorouracil—colon cancer	0.00224	0.00226	CcSEcCtD
Levobupivacaine—Flushing—Irinotecan—colon cancer	0.00218	0.0022	CcSEcCtD
Levobupivacaine—Cardiac disorder—Irinotecan—colon cancer	0.00218	0.0022	CcSEcCtD
Levobupivacaine—Cardiac arrest—Capecitabine—colon cancer	0.00216	0.00219	CcSEcCtD
Levobupivacaine—Urinary retention—Capecitabine—colon cancer	0.00216	0.00219	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Capecitabine—colon cancer	0.00213	0.00215	CcSEcCtD
Levobupivacaine—Mental disorder—Vincristine—colon cancer	0.00211	0.00214	CcSEcCtD
Levobupivacaine—Chills—Irinotecan—colon cancer	0.00211	0.00213	CcSEcCtD
Levobupivacaine—Arrhythmia—Irinotecan—colon cancer	0.0021	0.00212	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Capecitabine—colon cancer	0.00208	0.0021	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Methotrexate—colon cancer	0.00208	0.0021	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00205	0.00207	CcSEcCtD
Levobupivacaine—Back pain—Vincristine—colon cancer	0.00203	0.00205	CcSEcCtD
Levobupivacaine—Flatulence—Irinotecan—colon cancer	0.00202	0.00204	CcSEcCtD
Levobupivacaine—Arrhythmia—Fluorouracil—colon cancer	0.00201	0.00203	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00201	0.00203	CcSEcCtD
Levobupivacaine—Muscular weakness—Capecitabine—colon cancer	0.00201	0.00203	CcSEcCtD
Levobupivacaine—Back pain—Irinotecan—colon cancer	0.00198	0.002	CcSEcCtD
Levobupivacaine—Abdominal distension—Capecitabine—colon cancer	0.00198	0.002	CcSEcCtD
Levobupivacaine—Muscle spasms—Irinotecan—colon cancer	0.00197	0.00199	CcSEcCtD
Levobupivacaine—Dysphagia—Capecitabine—colon cancer	0.00196	0.00199	CcSEcCtD
Levobupivacaine—Erythema—Fluorouracil—colon cancer	0.00196	0.00198	CcSEcCtD
Levobupivacaine—Anaemia—Vincristine—colon cancer	0.00194	0.00196	CcSEcCtD
Levobupivacaine—Bronchospasm—Capecitabine—colon cancer	0.00193	0.00195	CcSEcCtD
Levobupivacaine—Agitation—Vincristine—colon cancer	0.00193	0.00195	CcSEcCtD
Levobupivacaine—Sweating increased—Capecitabine—colon cancer	0.00191	0.00193	CcSEcCtD
Levobupivacaine—Anaemia—Irinotecan—colon cancer	0.00189	0.00191	CcSEcCtD
Levobupivacaine—Vision blurred—Fluorouracil—colon cancer	0.00185	0.00187	CcSEcCtD
Levobupivacaine—Syncope—Irinotecan—colon cancer	0.00183	0.00185	CcSEcCtD
Levobupivacaine—Convulsion—Vincristine—colon cancer	0.00182	0.00184	CcSEcCtD
Levobupivacaine—Hypertension—Vincristine—colon cancer	0.00181	0.00183	CcSEcCtD
Levobupivacaine—Anaemia—Fluorouracil—colon cancer	0.00181	0.00183	CcSEcCtD
Levobupivacaine—Loss of consciousness—Irinotecan—colon cancer	0.0018	0.00182	CcSEcCtD
Levobupivacaine—Cough—Irinotecan—colon cancer	0.00179	0.0018	CcSEcCtD
Levobupivacaine—Hypertension—Irinotecan—colon cancer	0.00177	0.00179	CcSEcCtD
Levobupivacaine—Infestation—Capecitabine—colon cancer	0.00175	0.00177	CcSEcCtD
Levobupivacaine—Infestation NOS—Capecitabine—colon cancer	0.00175	0.00177	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00175	0.00177	CcSEcCtD
Levobupivacaine—Lethargy—Methotrexate—colon cancer	0.00173	0.00175	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Capecitabine—colon cancer	0.00172	0.00174	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Levobupivacaine—Oedema—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Levobupivacaine—Infection—Vincristine—colon cancer	0.0017	0.00172	CcSEcCtD
Levobupivacaine—Urinary tract infection—Capecitabine—colon cancer	0.0017	0.00172	CcSEcCtD
Levobupivacaine—Convulsion—Fluorouracil—colon cancer	0.0017	0.00172	CcSEcCtD
Levobupivacaine—Osteoarthritis—Methotrexate—colon cancer	0.00169	0.00171	CcSEcCtD
Levobupivacaine—Confusional state—Irinotecan—colon cancer	0.00168	0.0017	CcSEcCtD
Levobupivacaine—Nervous system disorder—Vincristine—colon cancer	0.00168	0.0017	CcSEcCtD
Levobupivacaine—Haematuria—Capecitabine—colon cancer	0.00167	0.00169	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Irinotecan—colon cancer	0.00167	0.00169	CcSEcCtD
Levobupivacaine—Oedema—Irinotecan—colon cancer	0.00167	0.00169	CcSEcCtD
Levobupivacaine—Infection—Irinotecan—colon cancer	0.00166	0.00168	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Vincristine—colon cancer	0.00166	0.00168	CcSEcCtD
Levobupivacaine—Shock—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Levobupivacaine—Nervous system disorder—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Irinotecan—colon cancer	0.00161	0.00163	CcSEcCtD
Levobupivacaine—Confusional state—Fluorouracil—colon cancer	0.00161	0.00163	CcSEcCtD
Levobupivacaine—Hypotension—Vincristine—colon cancer	0.0016	0.00162	CcSEcCtD
Levobupivacaine—Bradycardia—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Levobupivacaine—Oedema—Fluorouracil—colon cancer	0.0016	0.00162	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Fluorouracil—colon cancer	0.0016	0.00162	CcSEcCtD
Levobupivacaine—Infection—Fluorouracil—colon cancer	0.00159	0.00161	CcSEcCtD
Levobupivacaine—Nervous system disorder—Fluorouracil—colon cancer	0.00157	0.00159	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Capecitabine—colon cancer	0.00156	0.00158	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00156	0.00158	CcSEcCtD
Levobupivacaine—Tachycardia—Fluorouracil—colon cancer	0.00156	0.00158	CcSEcCtD
Levobupivacaine—Hypotension—Irinotecan—colon cancer	0.00156	0.00158	CcSEcCtD
Levobupivacaine—Insomnia—Vincristine—colon cancer	0.00155	0.00157	CcSEcCtD
Levobupivacaine—Oedema peripheral—Capecitabine—colon cancer	0.00155	0.00157	CcSEcCtD
Levobupivacaine—Paraesthesia—Vincristine—colon cancer	0.00154	0.00156	CcSEcCtD
Levobupivacaine—Insomnia—Irinotecan—colon cancer	0.00151	0.00153	CcSEcCtD
Levobupivacaine—Paraesthesia—Irinotecan—colon cancer	0.0015	0.00152	CcSEcCtD
Levobupivacaine—Hypotension—Fluorouracil—colon cancer	0.00149	0.00151	CcSEcCtD
Levobupivacaine—Decreased appetite—Vincristine—colon cancer	0.00149	0.00151	CcSEcCtD
Levobupivacaine—Dyspnoea—Irinotecan—colon cancer	0.00149	0.0015	CcSEcCtD
Levobupivacaine—Somnolence—Irinotecan—colon cancer	0.00148	0.0015	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Vincristine—colon cancer	0.00148	0.0015	CcSEcCtD
Levobupivacaine—Dyspepsia—Irinotecan—colon cancer	0.00147	0.00149	CcSEcCtD
Levobupivacaine—Tinnitus—Capecitabine—colon cancer	0.00147	0.00148	CcSEcCtD
Levobupivacaine—Constipation—Vincristine—colon cancer	0.00147	0.00148	CcSEcCtD
Levobupivacaine—Pain—Vincristine—colon cancer	0.00147	0.00148	CcSEcCtD
Levobupivacaine—Flushing—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Levobupivacaine—Cardiac disorder—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00146	0.00147	CcSEcCtD
Levobupivacaine—Decreased appetite—Irinotecan—colon cancer	0.00145	0.00147	CcSEcCtD
Levobupivacaine—Insomnia—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00144	0.00146	CcSEcCtD
Levobupivacaine—Paraesthesia—Fluorouracil—colon cancer	0.00144	0.00145	CcSEcCtD
Levobupivacaine—Constipation—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Levobupivacaine—Pain—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Levobupivacaine—Dyspnoea—Fluorouracil—colon cancer	0.00143	0.00144	CcSEcCtD
Levobupivacaine—Somnolence—Fluorouracil—colon cancer	0.00142	0.00144	CcSEcCtD
Levobupivacaine—Chills—Capecitabine—colon cancer	0.00141	0.00143	CcSEcCtD
Levobupivacaine—Dyspepsia—Fluorouracil—colon cancer	0.00141	0.00142	CcSEcCtD
Levobupivacaine—Arrhythmia—Capecitabine—colon cancer	0.00141	0.00142	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Vincristine—colon cancer	0.0014	0.00142	CcSEcCtD
Levobupivacaine—Decreased appetite—Fluorouracil—colon cancer	0.00139	0.00141	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00138	0.0014	CcSEcCtD
Levobupivacaine—Mental disorder—Capecitabine—colon cancer	0.00138	0.00139	CcSEcCtD
Levobupivacaine—Feeling abnormal—Irinotecan—colon cancer	0.00138	0.00139	CcSEcCtD
Levobupivacaine—Erythema—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Levobupivacaine—Malnutrition—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Levobupivacaine—Pain—Fluorouracil—colon cancer	0.00137	0.00138	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Irinotecan—colon cancer	0.00137	0.00138	CcSEcCtD
Levobupivacaine—Abdominal pain—Vincristine—colon cancer	0.00136	0.00137	CcSEcCtD
Levobupivacaine—Body temperature increased—Vincristine—colon cancer	0.00136	0.00137	CcSEcCtD
Levobupivacaine—Flatulence—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Levobupivacaine—Back pain—Capecitabine—colon cancer	0.00132	0.00134	CcSEcCtD
Levobupivacaine—Abdominal pain—Irinotecan—colon cancer	0.00132	0.00133	CcSEcCtD
Levobupivacaine—Body temperature increased—Irinotecan—colon cancer	0.00132	0.00133	CcSEcCtD
Levobupivacaine—Feeling abnormal—Fluorouracil—colon cancer	0.00132	0.00133	CcSEcCtD
Levobupivacaine—Muscle spasms—Capecitabine—colon cancer	0.00132	0.00133	CcSEcCtD
Levobupivacaine—Infestation—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Levobupivacaine—Drowsiness—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Levobupivacaine—Infestation NOS—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Levobupivacaine—Vision blurred—Capecitabine—colon cancer	0.00129	0.0013	CcSEcCtD
Levobupivacaine—Tremor—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Levobupivacaine—Urticaria—Fluorouracil—colon cancer	0.00127	0.00128	CcSEcCtD
Levobupivacaine—Anaemia—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Levobupivacaine—Body temperature increased—Fluorouracil—colon cancer	0.00126	0.00128	CcSEcCtD
Levobupivacaine—Hypersensitivity—Vincristine—colon cancer	0.00126	0.00128	CcSEcCtD
Levobupivacaine—Sweating—Methotrexate—colon cancer	0.00125	0.00126	CcSEcCtD
Levobupivacaine—Haematuria—Methotrexate—colon cancer	0.00124	0.00126	CcSEcCtD
Levobupivacaine—Hypersensitivity—Irinotecan—colon cancer	0.00123	0.00124	CcSEcCtD
Levobupivacaine—Asthenia—Vincristine—colon cancer	0.00123	0.00124	CcSEcCtD
Levobupivacaine—Syncope—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Levobupivacaine—Palpitations—Capecitabine—colon cancer	0.00121	0.00122	CcSEcCtD
Levobupivacaine—Loss of consciousness—Capecitabine—colon cancer	0.0012	0.00122	CcSEcCtD
Levobupivacaine—Asthenia—Irinotecan—colon cancer	0.0012	0.00121	CcSEcCtD
Levobupivacaine—Cough—Capecitabine—colon cancer	0.00119	0.00121	CcSEcCtD
Levobupivacaine—Hypertension—Capecitabine—colon cancer	0.00118	0.00119	CcSEcCtD
Levobupivacaine—Hypersensitivity—Fluorouracil—colon cancer	0.00118	0.00119	CcSEcCtD
Levobupivacaine—Diarrhoea—Vincristine—colon cancer	0.00117	0.00119	CcSEcCtD
Levobupivacaine—Arthralgia—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Levobupivacaine—Anxiety—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Levobupivacaine—Diarrhoea—Irinotecan—colon cancer	0.00114	0.00115	CcSEcCtD
Levobupivacaine—Dizziness—Vincristine—colon cancer	0.00113	0.00115	CcSEcCtD
Levobupivacaine—Pruritus—Fluorouracil—colon cancer	0.00113	0.00114	CcSEcCtD
Levobupivacaine—Confusional state—Capecitabine—colon cancer	0.00113	0.00114	CcSEcCtD
Levobupivacaine—Oedema—Capecitabine—colon cancer	0.00112	0.00113	CcSEcCtD
Levobupivacaine—Infection—Capecitabine—colon cancer	0.00111	0.00112	CcSEcCtD
Levobupivacaine—Dizziness—Irinotecan—colon cancer	0.0011	0.00112	CcSEcCtD
Levobupivacaine—Shock—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Levobupivacaine—Nervous system disorder—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Levobupivacaine—Diarrhoea—Fluorouracil—colon cancer	0.00109	0.00111	CcSEcCtD
Levobupivacaine—Tinnitus—Methotrexate—colon cancer	0.00109	0.0011	CcSEcCtD
Levobupivacaine—Tachycardia—Capecitabine—colon cancer	0.00109	0.0011	CcSEcCtD
Levobupivacaine—Vomiting—Vincristine—colon cancer	0.00109	0.0011	CcSEcCtD
Levobupivacaine—Cardiac disorder—Methotrexate—colon cancer	0.00109	0.0011	CcSEcCtD
Levobupivacaine—Skin disorder—Capecitabine—colon cancer	0.00109	0.0011	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Capecitabine—colon cancer	0.00108	0.00109	CcSEcCtD
Levobupivacaine—Headache—Vincristine—colon cancer	0.00107	0.00109	CcSEcCtD
Levobupivacaine—Vomiting—Irinotecan—colon cancer	0.00106	0.00107	CcSEcCtD
Levobupivacaine—Dizziness—Fluorouracil—colon cancer	0.00106	0.00107	CcSEcCtD
Levobupivacaine—Chills—Methotrexate—colon cancer	0.00105	0.00106	CcSEcCtD
Levobupivacaine—Headache—Irinotecan—colon cancer	0.00105	0.00106	CcSEcCtD
Levobupivacaine—Hypotension—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Levobupivacaine—Mental disorder—Methotrexate—colon cancer	0.00103	0.00104	CcSEcCtD
Levobupivacaine—Malnutrition—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Levobupivacaine—Erythema—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Levobupivacaine—Nausea—Vincristine—colon cancer	0.00102	0.00103	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00102	0.00103	CcSEcCtD
Levobupivacaine—Vomiting—Fluorouracil—colon cancer	0.00102	0.00103	CcSEcCtD
Levobupivacaine—Insomnia—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Levobupivacaine—Paraesthesia—Capecitabine—colon cancer	0.001	0.00101	CcSEcCtD
Levobupivacaine—Headache—Fluorouracil—colon cancer	0.001	0.00101	CcSEcCtD
Levobupivacaine—Dyspnoea—Capecitabine—colon cancer	0.000996	0.00101	CcSEcCtD
Levobupivacaine—Nausea—Irinotecan—colon cancer	0.000992	0.001	CcSEcCtD
Levobupivacaine—Back pain—Methotrexate—colon cancer	0.000986	0.000997	CcSEcCtD
Levobupivacaine—Dyspepsia—Capecitabine—colon cancer	0.000984	0.000994	CcSEcCtD
Levobupivacaine—Decreased appetite—Capecitabine—colon cancer	0.000971	0.000982	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000965	0.000975	CcSEcCtD
Levobupivacaine—Vision blurred—Methotrexate—colon cancer	0.000961	0.000971	CcSEcCtD
Levobupivacaine—Pain—Capecitabine—colon cancer	0.000956	0.000966	CcSEcCtD
Levobupivacaine—Constipation—Capecitabine—colon cancer	0.000956	0.000966	CcSEcCtD
Levobupivacaine—Nausea—Fluorouracil—colon cancer	0.00095	0.00096	CcSEcCtD
Levobupivacaine—Anaemia—Methotrexate—colon cancer	0.000942	0.000952	CcSEcCtD
Levobupivacaine—Feeling abnormal—Capecitabine—colon cancer	0.000921	0.000931	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Capecitabine—colon cancer	0.000914	0.000924	CcSEcCtD
Levobupivacaine—Cough—Methotrexate—colon cancer	0.000889	0.000899	CcSEcCtD
Levobupivacaine—Urticaria—Capecitabine—colon cancer	0.000888	0.000897	CcSEcCtD
Levobupivacaine—Body temperature increased—Capecitabine—colon cancer	0.000883	0.000893	CcSEcCtD
Levobupivacaine—Abdominal pain—Capecitabine—colon cancer	0.000883	0.000893	CcSEcCtD
Levobupivacaine—Convulsion—Methotrexate—colon cancer	0.000883	0.000893	CcSEcCtD
Levobupivacaine—Arthralgia—Methotrexate—colon cancer	0.000868	0.000877	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000862	0.000871	CcSEcCtD
Levobupivacaine—Confusional state—Methotrexate—colon cancer	0.000839	0.000848	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Methotrexate—colon cancer	0.000832	0.000841	CcSEcCtD
Levobupivacaine—Infection—Methotrexate—colon cancer	0.000826	0.000835	CcSEcCtD
Levobupivacaine—Hypersensitivity—Capecitabine—colon cancer	0.000823	0.000832	CcSEcCtD
Levobupivacaine—Nervous system disorder—Methotrexate—colon cancer	0.000816	0.000825	CcSEcCtD
Levobupivacaine—Skin disorder—Methotrexate—colon cancer	0.000808	0.000817	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Methotrexate—colon cancer	0.000804	0.000813	CcSEcCtD
Levobupivacaine—Asthenia—Capecitabine—colon cancer	0.000802	0.00081	CcSEcCtD
Levobupivacaine—Pruritus—Capecitabine—colon cancer	0.000791	0.000799	CcSEcCtD
Levobupivacaine—Hypotension—Methotrexate—colon cancer	0.000777	0.000786	CcSEcCtD
Levobupivacaine—Diarrhoea—Capecitabine—colon cancer	0.000765	0.000773	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000758	0.000766	CcSEcCtD
Levobupivacaine—Insomnia—Methotrexate—colon cancer	0.000752	0.000761	CcSEcCtD
Levobupivacaine—Paraesthesia—Methotrexate—colon cancer	0.000747	0.000755	CcSEcCtD
Levobupivacaine—Dyspnoea—Methotrexate—colon cancer	0.000742	0.00075	CcSEcCtD
Levobupivacaine—Somnolence—Methotrexate—colon cancer	0.00074	0.000748	CcSEcCtD
Levobupivacaine—Dizziness—Capecitabine—colon cancer	0.000739	0.000747	CcSEcCtD
Levobupivacaine—Dyspepsia—Methotrexate—colon cancer	0.000732	0.00074	CcSEcCtD
Levobupivacaine—Decreased appetite—Methotrexate—colon cancer	0.000723	0.000731	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000718	0.000726	CcSEcCtD
Levobupivacaine—Pain—Methotrexate—colon cancer	0.000711	0.000719	CcSEcCtD
Levobupivacaine—Vomiting—Capecitabine—colon cancer	0.00071	0.000718	CcSEcCtD
Levobupivacaine—Headache—Capecitabine—colon cancer	0.0007	0.000708	CcSEcCtD
Levobupivacaine—Feeling abnormal—Methotrexate—colon cancer	0.000685	0.000693	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Methotrexate—colon cancer	0.00068	0.000688	CcSEcCtD
Levobupivacaine—Nausea—Capecitabine—colon cancer	0.000664	0.000671	CcSEcCtD
Levobupivacaine—Urticaria—Methotrexate—colon cancer	0.000661	0.000668	CcSEcCtD
Levobupivacaine—Abdominal pain—Methotrexate—colon cancer	0.000658	0.000665	CcSEcCtD
Levobupivacaine—Body temperature increased—Methotrexate—colon cancer	0.000658	0.000665	CcSEcCtD
Levobupivacaine—Hypersensitivity—Methotrexate—colon cancer	0.000613	0.00062	CcSEcCtD
Levobupivacaine—Asthenia—Methotrexate—colon cancer	0.000597	0.000603	CcSEcCtD
Levobupivacaine—Pruritus—Methotrexate—colon cancer	0.000589	0.000595	CcSEcCtD
Levobupivacaine—Diarrhoea—Methotrexate—colon cancer	0.000569	0.000575	CcSEcCtD
Levobupivacaine—Dizziness—Methotrexate—colon cancer	0.00055	0.000556	CcSEcCtD
Levobupivacaine—Vomiting—Methotrexate—colon cancer	0.000529	0.000535	CcSEcCtD
Levobupivacaine—Headache—Methotrexate—colon cancer	0.000521	0.000527	CcSEcCtD
Levobupivacaine—Nausea—Methotrexate—colon cancer	0.000494	0.000499	CcSEcCtD
